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ABSTRACT 
Objective: We hypothesized that prenatal stress (PS) exerts lasting impact on fetal heart rate (fHR). We 
sought to validate the presence of such PS signature in fHR by measuring coupling between maternal 
HR (mHR) and fHR. 
Study design: Prospective observational cohort study in stressed group (SG) mothers with controls 
matched for gestational age during screening at third trimester using Cohen Perceived Stress Scale (PSS) 
questionnaire with PSS-10 ≥ 19 classified as SG. Women with PSS-10 < 19 served as control group (CG).  
Setting: “Klinikum rechts der Isar” of the Technical University of Munich. 
Population: Singleton 3rd trimester pregnant women. 
Methods: Transabdominal fetal electrocardiograms (fECG) were recorded. We deployed a signal-
processing algorithm termed bivariate phase-rectified signal averaging (BPRSA) to quantify coupling 
between mHR and fHR resulting in a fetal stress index (FSI). Maternal hair cortisol was measured at birth. 
Main Outcome Measures: Differences for FSI between both groups. 
Results: We screened 1500 women enrolling 538 of which 16.5 % showed a PSS-10 score ≥ 19 at 34+0 
weeks. Fifty five women eventually comprised the SG and n=55 served as CG. Median PSS was 22.0 (IQR 
21.0-24.0) in the SG and 9.0 (6.0-12.0) (p<0.001) in the CG, respectively. Maternal hair cortisol was 
higher in SG than CG at 86.6 (48.0-169.2) versus 53.0 (34.4-105.9) pg/mg (p=0.029). At 36+5 weeks, FSI 
was significantly higher in fetuses of stressed mothers when compared to controls [0.43 (0.18-0.85) 
versus 0.00 (-0.49-0.18), p<0.001].  
Conclusion: Our findings show a persistent effect of PS affecting fetuses in the last trimester.  
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INTRODUCTION 
Prenatal exposure to maternal psychosocial stress, depression and anxiety confers lifelong risk 
for behavioral alterations that last beyond childhood 1. Every fifth to fourth pregnant women 
experiences such prenatal stress (PS) 2. Considering the difficulty to differentiate the concept of stress 
(including the psychological assessment of perceived stress) from anxiety, we will employ the term 
‘psychosocial stress’ to refer to maternal general and pregnancy-specific stress and anxiety throughout 
this study  3,4. The mechanisms of the physiological stress response can be divided into an acute 
response, which involves the rapid activation of the autonomic nervous system (ANS), and a delayed 
response mediated by the hypothalamic–pituitary–adrenal (HPA) axis. The neurally mediated ANS 
responses enable precise adjustments of target organs within seconds, while the HPA’s slow response 
results in peak levels of cortisol within 10-30 min after acute stressor 5. Most importantly, these 
maternal stress responses shape the development of the infant’s stress response system, a 
phenomenon referred to as “fetal programming”. It is the main mechanism by which prenatal exposures 
influence human postnatal development  6. We hypothesized that the coordinated roles of the ANS and 
the HPA in the integrated stress response can be monitored non-invasively using electrocardiogram (ECG) 
and ECG-derived maternal and fetal heart rate (mHR, fHR). The relationship between mHR and fHR 
might provide important information about the functional status of fetal ANS 7 . In a prospective cohort 
of late-gestation women, we tested whether a new biomarker measuring the coupling of mHR and fHR 
can predict the preceding chronic exposure of mothers to stress. Herein, we propose a novel analysis 
method of coupling between mHR and fHR based on a signal-processing algorithm, first applied in adult 
cardiology, termed bivariate phase-rectified signal averaging (BPRSA) 8,9 and applied to trans-
abdominally acquired fetal ECG (fECG). This method overcomes the limitation of non-stationary signal 
and background noise typical for fHR signal.  
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Such physiological biomarkers could serve as foundation for prediction of the child 
neurodevelopmental outcomes and aid in devising early developmental intervention strategies for 
children at risk of altered neurodevelopmental trajectories due to prenatal stress exposure. The aim of 
the study was to: 1) evaluate the coupling between mHR and fHR by BPRSA analysis; and 2) compare 
BPRSA results of fetal response to mHR changes in healthy controls and stressed fetuses. 
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METHODS  
Study design and study population: 
We performed a prospective observational cohort study in stressed mothers with controls matched for 
gestational age at screening. Subjects were recruited for 22 months (July 2016 until May 2018) from a 
cohort of pregnant women followed in the Department of Obstetrics and Gynecology at “Klinikum 
rechts der Isar” of the Technical University of Munich (TUM), a tertiary center of Perinatology located 
in Munich, Germany, serving ~2000 mothers/newborns per year.  
Experimental design: 
TUM obstetricians identified prospective subjects according to the following inclusion criteria: singleton 
pregnant women between 18 to 45 years of age in their third trimester (at least 28 weeks gestation). 
Exclusion criteria were a) serious placental alterations; b) fetal malformations; c) maternal severe illness 
during pregnancy and d) maternal drug or alcohol abuse. 
The participants entered Phase I-III of the study (Figure S1): 
 
Phase I: Screening:  
We administered Cohen Perceived Stress Scale questionnaire (PSS-10). PSS-10 categorized them as SG 
for PSS-10 score ≥19 2. For every subject categorized as stressed, the next screened participant matching 
for gestational age at recording with a PSS-10 score < 19 was entered into Phase II as control.  
 
Phase II: Maternal and fetal prenatal ANS assessment: 
Prospective participants attended an informational session, when procedures were explained, formal 
enrollment completed and the consent forms from the participants obtained. We collected 
demographic information from the consented women.  
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Two and a half weeks after screening, we performed a transabdominal ECG (taECG) recording at 900 Hz 
sampling rate of at least 40 minutes duration using AN24 (GE HC/Monica Health Care, Nottingham, UK).  
We applied the fetal ECG extraction algorithm SAVER 10 to detect the fetal R-peaks and the maternal R-
peaks in the taECG separately. With the fetal and maternal R-peaks, we obtained the fetal and maternal 
RR interval time series. The quality of taECG was estimated by the calculation of signal quality index 
(SQI) within windows of one second each. Regions where SQI was lower than 0.5 were marked as 
artifacts and were not considered for the analysis. Mean fetal heart rate and mean maternal heart rate 
were calculated. Mean maternal respiratory rate was derived from taECG and calculated according to 
Sinnecker et al 11.  
Phase III: Delivery:  
Newborn recordings: Clinical data including body metrics, pH and Apgar score, were recorded.  
Maternal cortisol assessment: On the day of parturition, hair strands (~3 mm diameter) were collected 
from the posterior vertex region on the head as close to the scalp as possible 12. Hair samples were sent 
to the Department of Clinical Biochemistry (Endocrinology Section) of the Faculty of Pharmacy and 
Biochemistry (University of Buenos Aires) for cortisol measurement using autoanalyzers. Based on an 
approximate hair growth rate of 1 cm per month, the proximal 3 cm long hair segment is assumed to 
reflect the integrated hormone secretion over the three-month-period prior to sampling. The 3 cm hair 
sample was wrapped in aluminum foil for protection and stored at room temperature up to three 
months. Fifty milligrams of hair obtained from the 3 centimeters closest to the roots (equivalent to 3 
months of growth), were weighed in an analytical balance, as recommended by the Society of Hair 
Testing 12. The weighted hair was cut with scissors into small pieces and put into a glass test tube with 
emery boards and 4 ml of methanol added. The tube was sealed with a cap and incubated in a shaking 
bath for 3 h at room temperature and then overnight at 50°C, for the steroid extraction. After incubation, 
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the tubes were shaken 1 minute in a Vortex and 0.6 ml of the supernatant was collected in Khan glass 
tubes and evaporated until dryness at room temperature (24-48 h). The dry remnant was reconstituted 
with 300 µl in MD1 multidiluent for Immulite, provided by Siemens, and this sample was vortexed for 1 
minute until its processing. The extracted cortisol was measured in Immulite 2000 ® automated CLIA 
analyzer as previously reported by our Laboratory for salivary cortisol 13. This procedure has been 
validated with the standard method of mass spectrometry and was patented by the University of 
Buenos Aires 13. 
 
Measurement of maternal stress during pregnancy: 
Maternal psychosocial stress was measured using the Cohen Perceived Stress Scale (PSS 10). This 
questionnaire measures the degree to which situations in one’s life are appraised as stressful and is a 
widely used psychological instrument to measure nonspecific perceived stress 14. The PSS-10 predicts 
objective biological markers of stress and increased risk for disease among persons with higher 
perceived stress levels. Increased maternal prenatal stress, measured by PSS-10, was associated with 
temperamental variation of young infants and may represent a risk factor for psychopathology later in 
life 15. The PSS-10 has been validated in German speaking populations and is a quick tool for screening 
stress among prospective subjects 16-18. 
There is no recommended cut-point for high stress; and other studies have stratified this continuous 
variable using study-specific thresholds 2,19. In our case, we performed a pilot study and we found that 
the 80% quantile of the PSS-10 was 19, which was then used as the cut-off score for stressed (SG) and 
control group (CG) in this study in accordance to prior studies 2,19. 
 
Bivariate phase-rectified signal averaging (BPRSA) 
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The bivariate PRSA method is an extension of the “monovariate” PRSA method that we introduced for 
the analysis of fetal heart rate 20,21. 
BPRSA allows for identifying and quantifying relationships between two synchronously recorded signals 
8. In this study these two signals are the maternal heart rate (mHR) as the trigger signal and the fetal 
heart rate (fHR) as the target signal.  
The algorithm of BPRSA consist of four steps: 
1.) At the beginning we identify all decreases in mHR and mark them as so called anchor points A.  
2.) To investigate the response of the fetus at the defined anchor points the fHR is interpolated with a 
sample rate of 900 Hz as maternal ECG is registered with 900 Hz.  Anchor points are identified by the 
time of occurrence within the fHR and are denoted as A’. 
 Segments of length 2L around each anchor A’ are selected in the fHR signal. In the current study we 
used L = 9000 samples, which correspond to a window of 20 seconds. 
3.) All segments are aligned at the anchors leading to a phase-rectification of the segments. The BPRSA-
signal X is obtained by averaging the aligned segments. Deflections in the BPRSA-signal can be 
interpreted as coupling between mHR and fHR.  
4.) Finally, the BPRSA-signal X is quantified within a defined time span prior to and after the center of X. 
The time span starts 1.5 seconds after the center and ends at 2.5 seconds after the center. Therefore 
we use S1 and S2 as additional indices for the quantification. The data frame after the center is defined 
as L+S1 up to L+S2. On the other side, the data frame prior to the center is defined as L-S2 up to L-S1. 
Using S1 = 1350 and S2 = 2250 reflects the sample rate of 900 Hz in the BPRSA signal X and corresponds 
to 1.5 seconds and 2.5 seconds respectively. Coupling between mHR and fHR was analyzed by BPRSA 
resulting in a new parameter called fetal stress index (FSI). FSI is quantified by calculating the difference 
between the mean values of the data frames after and prior the center of X.  
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Note that the center of X (at indices L) corresponds to our anchor definition which was performed within 
the mRRI. Thus the FSI measures the response of the fetus on maternal heart rate decreases. 
 
 
Statistics 
Normal distribution was tested using Shapiro-Wilk test. For skewed distribution, medians and 
interquartile ranges were reported and for Gaussian distribution, mean and standard deviation. For 
categorical data, we show the absolute and relative frequencies. For comparison between groups, 
Mann-Whitney U tests, t-test for independent samples and Pearson Chi squared test were used. 
Receiver operating characteristics (ROC) analyses were performed to estimate the predictive 
performance of the quantitative variables for the presence of PS 
For each fetus and mother, the fHR and mHR recorded at the same time were analyzed.  
Finally, Pearson’s correlation coefficient was used to evaluate the relationship between the fHR and 
mHR. All statistical tests were conducted two-sided and a p-value <0.05 was considered statistically 
significant for all comparisons. The fetal HR extraction algorithm was carried out in MatlabR2016a. 
Statistical analysis was performed using IBM SPSS Statistics for Windows, version 25 (IBM Corp., Armonk, 
N.Y., USA). 
 
Study approval and funding 
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The study protocol is in strict accordance with the Committee of Ethical Principles for Medical Research 
from TUM and has the approval of the “Ethikkommission der Fakultät für Medizin der Technischen 
Universität München” (registration number 151/16S). ClinicalTrials.gov registration number is 
NCT03389178. Written informed consent was received from participants prior to inclusion in the study. 
There was no funding for the study. The project was developed and performed by own resources of 
Frauenklinik/Klinikum rechts der Isar. 
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RESULTS 
Sociodemographic parameters and perinatal outcomes 
Between July 2016 and May 2018 we enrolled and followed 55 SG and 55 CG subjects. The cohort 
characteristics and perinatal outcome variables are summarized in Table 1. 
Of all 1500 screened women, 538 returned the questionnaire and 16.5 % scored ≥ 19 on PSS-10 
classifying as SG (Figure S2). Based on recruitment criteria, SG comprised 55 subjects and CG comprised 
55 subjects at a similar median gestational age of 34.0 weeks. Median PSS of the SG was 22.0 (1st - 3rd 
quartile: 21.0-24.0) and that of the CG 9.0 (6.0-12.0) (p<0.001), respectively. The cortisol in maternal 
hair was 63% higher in SG versus CG (p=0.029) confirming the PSS results. The correlation of PSS and 
cortisol in hair was 0.182, no statistically significant association was observed (p=0.098). Area under the 
ROC curve for hair cortisol (prediction PS) was 0.639 (p=0.029). 
The pre-gestational [24.2 (20.9-30.8) versus 21.5 (20.2-23.5), p=0.001] and at-study-inclusion [29.8 
(26.0-36.7) versus 26.1 (24.5-28.7), p=0.001] median BMI of the SG patients was higher. Cord blood 
arterial pO2 was lower in the SG fetuses [17.9 (13.0-23.0) versus 21.1 (17.0-26.2) mmHg, p=0.035]. 
There were 9 times as many women in the SG diagnosed with gestational diabetes mellitus (GDM) than 
in the CG (p=0.008) and 5 times as many diagnosed with cases of autoimmune diseases (p=0.014). 
Smoking was more frequent in the SG (p=0.028) and the number of planned pregnancies was lower in 
the SG than in the CG (p=0.001).  
Less SG subjects visited university (p=0.001) and had the monthly net-income per household above 
5000€ (p=0.002). More than two times as many SG than CG subjects ended up in cesarean delivery 
(p=0.007). 
 
BPRSA 
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Data from 104 out of 110 subjects were used, because 6 subjects had poor ECG signal quality (2 CG 
fetuses and 4 SG). 
Mean mHR, mean maternal respiratory rate calculated from mECG and median fHR were similar in both 
groups. Median FSI was significantly higher in SG compared to controls [0.43 (0.18-0.85) versus 0.00 (-
0.49-0.18), p<0.001](Figure 1). That means that SG fetuses showed fHR decreases whereas CG fetuses 
remained “relaxed” after the maternal anchor “mHR decreases”. This difference remained significant 
even after adjustment of relevant socioeconomic differences between both groups (BMI, university 
degree, household income> 5000€/month, smoking, planned pregnancy, diabetes, autoimmune 
diseases; p=0.012). Area under the receiver operating characteristics curve was 0.748 (p<0.001) (Figure 
2). Figure 3 illustrates BPRSA results- the fetal response to maternal heart rate decreases. 
Apart, we found a significant correlation of PSS and FSI (r=0.34, p<0.001). 
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DISCUSSION 
MAIN FINDINGS 
PS identified in the 3rd trimester impacts fetal physiology until delivery as evidenced by the 
altered fHR properties in fetuses of SG mothers and by the lower fetal oxygenation at birth.  
The proposed BPRSA index (FSI) provides unique insights into the relationship between two 
biological systems - mother and fetus. In this study we could detect periodic mHR decreases reflecting 
typical pattern of maternal breathing (sinus bradycardia during expiration). Interestingly, CG fetuses 
remained “stable” during these periods whereas fetuses of stressed mothers showed significant 
decreases of fHR.  
 
INTERPRETATION 
We hypothesize that this response is induced by the mechanical stimuli (diaphragm excursion 
which changes the uterine pressure). Future studies will need to address the question why CG fHR 
remained unchanged whereas SG showed decreased fHR during maternal breathing. A possible 
explanation might be the “over-sensitization” of SG fetuses’ HPA axis or the differences in maturation 
of the sympathetic and parasympathetic branches of the ANS in contrast to the CG similar to data 
derived from animal models where lower weight twin sheep fetuses showed increased sympathetic 
activity and immaturity of circulatory control22. Physiologically, the ability of two complex weakly 
coupled systems to entrain each other is influenced by their intrinsic oscillatory properties and 
maturation, respectively. A well-studied example can be found in the cardiac pacemaker physiology 23.  
Fetal ANS is very sensitive to maternal stress 24-26 and common markers of ANS such as fHR 
reactivity to a stimulus, reflect emerging individual differences in the development of the autonomic 
and central nervous systems related to styles of future emotional regulation and risk for 
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psychopathology27,28. It is hence likely that the fHR response to mHR changes represents a fetal stress 
memory and may serve as a novel biomarker to detect PS effects early in utero which may help guide 
early interventions postnatally. For example, PS was linked to increased risk for autism spectrum 
disorder and alterations of ANS in autism spectrum disorders children have been reported 29,30. 
We observed a mild fetal hypoxia at birth compatible with the concept of chronic reduction of 
uterine blood flow due to PS 31. The result may be a reduced placental catecholamine clearance, thus 
elevating fetal catecholamine levels with hyperactive HPA axis and sympathetic nervous system. The 
postnatal developmental sequelae of these adaptations remain to be elucidated. 
The persistent exposure to stress is validated on the maternal side by the higher maternal 
chronic cortisol levels at delivery in SG compared to CG. Perceived (subjective) measures of maternal 
stress did not correlate well with maternal cortisol at delivery in our study. This agrees with the body of 
inconclusive evidence seeking to link subjective stress exposure with cortisol values. Hair cortisol also 
appears to be a better biomarker than salivary cortisol for evaluation of the effectiveness of a stress 
reduction program in graduate students 32. Meanwhile, other studies performed in women during or 
after pregnancy showed a lack of correlation.  For example, in 768 mothers recruited shortly after 
delivery, hair cortisol did not correlate with self-reports of chronic stress, anxiety, or depressive 
symptomatology 33. In a larger study involving 3039 pregnant women, maternal cortisol during 
pregnancy was mainly affected by biological and lifestyle factors, but not by psychosocial factors34. 
Moreover, hair cortisol and cortisone measured in pregnant women in their 2ndand 3rdtrimester 
correlated with self-reported stress in both trimesters only with cortisol/cortisone metabolism, but not 
with cortisol alone 35. While the lack of correlation may be due to questionnaire-based assessments or, 
the inherently high cortisol levels during pregnancy, the most likely cause is the presence of mechanisms 
mediating PS effects that do not alter maternal cortisol levels. fHR changes may be a good biomarker of 
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such a mechanism as evidenced by our finding that FSI was more predictive of the subjective stress 
perception than cortisol. This result is in line with the psychological body of work such as the polyvagal 
theory 36 where heart rate variability has served as a good biomarker of internal emotional regulation 
which, in turn, reflects upon subjective coping with daily  stress. Such complex relationships may 
represent physiologically more stable traits and hence correlate better than cortisol. Cortisol, even 
when measured from hair where it is supposed to serve as a stress memory of prior 2-3 months of 
exposure, remains still a single molecule biomarker. As such, it may be less capable of carrying a steady-
state trait-like imprint than the FSI. 
 
STRENGTHS AND LIMITATIONS 
Our study has several strengths and limitations. One of the strengths is the prospective 
observational study design including women experiencing daily hassles stress rather than life events or 
natural disasters stress. We believe this makes the findings generalizable onto population of pregnant 
women seen in most antepartum follow-up centers. Our demographic data indicated distinct features 
of SG and CG regarding metabolic and socioeconomic status. This may be seen as a confounding factor 
for FSI, but even after adjustment for these possible confounders the difference of FSI between both 
groups remains significant. With an objective and low-cost biomarker of PS impact on mother and fetus 
in hand, prevention should be the subject of the future studies. A limitation of the study is that not all 
of the screened “control” women could be included into Phase II and III of the study due to limited 
“manpower”.  However, since all women qualifying as SG were enrolled, but not all controls, we suggest 
this had no impact on the reported differences due to PS.  
 
OUTLOOK 
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Our findings warrant further investigations into the mechanisms of maternal-fetal stress transfer 
under the widely prevalent conditions of daily hassles (as opposed to extreme stress exposures), 
identification of epigenetic biomarkers impacting the stress axis and ANS activity and postnatal 
consequences of intrauterine imprinting of maternal stress upon fetal physiology. At present we are  
following up the offspring’s neurodevelopment at  24 months and testing the feasibility of using a 
composite biomarker panel from salivary DNA as an early and non-invasive means in PS-exposed infants 
and fHR analysis to detect PS-induced ANS alterations that occur during fetal development 37. 
 
CONCLUSION 
In conclusion, we validated our hypothesis that PS-induced programming is reflected in mHR and 
fHR biomarkers of ANS activity. The biomarkers we identified can be harnessed for early detection and 
follow-up of children affected by PS. Early detection of altered neurodevelopmental trajectories opens 
new possibilities for designing more timely and effective interventions to improve outcomes of 
pregnancy affected by PS. 
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Table/figure caption list: 
 
Table 1: Study outcome parameters 
 
Figure 1:  Box plots using bivariate phase-rectified signal averaging (BPRSA) method comparing controls 
(CG, blue) and stress group (SG, red) 
Figure 2:  Area under the ROC curve for prediction of maternal stress using bivariate phase-rectified 
signal averaging method 
 Figure 3: BPRSA analysis of fRRI. upper) PRSA signal X for maternal RR intervals. The anchor point 
definition, namely all heart rate deceleration, reflect the central oscillation of X. lower) The response of 
fetal RR intervals on the maternal decreases. The signal of the control BPRSA shows a significant lower 
response than the BPRSA curve for the fetus of a stressed mother. Also shown is the time span which is 
used for the quantification of FSI (yellow).   
Figure S1:  Study procedures 
Figure S2: Recruitment chart 
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Table 1:  
 
Characteristics Control Prenatal stress  
  n=55 n=55 p 
Baseline      
 gestational age at screening (weeks) 34.0 (33.4-335.0) 34.0 (32.7-35.1) 0.626 
 gestational age at inclusion (weeks) 36.7 (35.0-37.4) 36.4 (35.4-37.4) 0.844 
 maternal age (years) 35.2 (3.5)  33.8 (5.4) 0.108 
 BMI pregestational (kg/m²) 21.5 (20.2-23.5) 24.2 (20.9-30.8) 0.001* 
 BMI at inclusion (kg/m²) 26.1 (24.5-28.7) 29.8 (26.0-36.7) <0.001* 
 european / caucasian 50 (90.9) 51 (92.7) 0.728 
 married 41 (74.5) 39 (70.9) 0.669 
 university degree 45 (81.8) 29 (52.7) 0.001* 
 household income> 5000€/month 35  (63.6) 19 (34.5) 0.002* 
 smoking 1 (1.8) 7 (12.7) 0.028* 
 multiparity 22 (40.0) 30 (54.5) 0.127 
 planned pregnancy 50 (91.0) 36 (65.5) 0.001* 
 IVF / ICSI 6 (10.9) 2 (3.6) 0.142 
 gestational diabetes 1 (1.8) 9 (16.4) 0.008* 
 autoimmune disease 2 (3.6) 10 (18.2) 0.014* 
 working status at screening 2 (3.6) 4 (7.2) 0.388 
 score PSS-10 9.0 (6.0-12.0) 22.0 (21.0-24.0) <0.001* 
 cortisol in maternal hair (pg/mg)1 53.0 (34.4-105.9) 86.6 (48.0-169.2) 0.029* 
 maternal heart rate (bpm) 87.0 (10.6) 88.7 (9.3) 0.382 
 maternal respiratory rate 27.9 (3.6) 28.4 (3.6) 0.437 
 fetal heart rate (bpm) 140 (136-146 140 (136-147) 0.995 
 FSI (ms) 0.00 (-0.49-0.18) 0.43 (0.18-0.85) <0.001* 
Perinatal outcome      
 gestational age at delivery (weeks) 40.0 (39.0-40.7) 39.4 (38.6-40.6) 0.058 
 cesarean delivery 10 (18.2) 23 (41.8) 0.007* 
 gender female 24 (43.6) 20 (36.45) 0.436 
 birthweight (g) 3560 (412) 3552 (470) 0.922 
 birthweight percentile 52.1 (25.0) 57.6 (25.7) 0.270 
 length (cm) 53.0 (51.0-55.0) 53.0 (52.0-55.0) 0.591 
 head circumference (cm) 35.0 (34.0-36.0) 35.0 (34.0-36.0) 0.437 
 Apgar min 5 10.0 (9.0-10.0) 10.0 (9.0-10.0) 0.173 
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 Apgar min 10 10.0 (10.0-10.0) 10.0 (10.0-10.0) 0.280 
 5-min Apgar<7 4 (7.2) 2 (3.6) 0.388 
 admission to NICU 2 (3.6) 3 (5.4) 0.647 
Arterial cord blood analysis results      
 pH 7.25(0.09) 7.28 (0.08) 0.137 
 umbilical artery pH <=7.15 5 (9.1) 3 (5.4) 0.430 
 base excess, mmol/l -5.4 (3.4) -4.9 (3.0) 0.431 
 pO2, mmHg 21.1 (17.0-26.2) 17.9 (13.0-23.0) 0.035* 
 pCO2, mmHg 51.2 (11.1) 50.7 (9.4) 0.826 
 lactate mmol/l 4.1 (1.4) 4.0 (1.6) 0.861 
 glucose, mg/dl 81.7 (20.8) 75.5 (19.0) 0.187 
Data are median (interquartile range) or mean (SD) or n (%). 
    
PSS: Perceived stress scale; BMI: Body-mass index; NICU: Neonatal intensive care unit;  
* p < 0.05, 1missing data of 14 CG and 17 SG; 0: control group (PSS<19) 1: stress group (PSS≥19) 
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